NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
(Total Views: 279)
Posted On: 10/10/2018 6:09:04 PM
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Unveils Four New Subsidiary Companies
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced the creation of four new wholly-owned subsidiary companies: Lexaria CanPharm Corp., a Canadian company that provides DehydraTECH technology and other enhancements to the global cannabis industry; Lexaria Nicotine Corp., a US company with a global license to offer DehydraTECH technology to the global nicotine and tobacco industries; Lexaria Hemp Corp., a US company globally licensed to provide DehydraTECH to the burgeoning hemp-based foods and supplements industries; and Lexaria Pharmaceutical Corp., a US company internationally authorized to license DehydraTECH to the pharmaceutical sector, including pain relief, vitamins, hormone treatments, central nervous system conditions and more. To greater engage with the separate customer bases and business applications for each subsidiary, this new corporate structure enables Lexaria to focus its future research, potential financing structures and industry partnerships on options specifically suited for each new subsidiary. The company also plans to use wholly-owned Poviva Tea Corp. to advance the current ViPova Tea and Coffee consumer brands. In addition, Lexaria announced that it has received $33,000 from the exercise of 330,000 options at the price of $0.10 previously granted to a third party. The proceeds will be used for general corporate purposes.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced the creation of four new wholly-owned subsidiary companies: Lexaria CanPharm Corp., a Canadian company that provides DehydraTECH technology and other enhancements to the global cannabis industry; Lexaria Nicotine Corp., a US company with a global license to offer DehydraTECH technology to the global nicotine and tobacco industries; Lexaria Hemp Corp., a US company globally licensed to provide DehydraTECH to the burgeoning hemp-based foods and supplements industries; and Lexaria Pharmaceutical Corp., a US company internationally authorized to license DehydraTECH to the pharmaceutical sector, including pain relief, vitamins, hormone treatments, central nervous system conditions and more. To greater engage with the separate customer bases and business applications for each subsidiary, this new corporate structure enables Lexaria to focus its future research, potential financing structures and industry partnerships on options specifically suited for each new subsidiary. The company also plans to use wholly-owned Poviva Tea Corp. to advance the current ViPova Tea and Coffee consumer brands. In addition, Lexaria announced that it has received $33,000 from the exercise of 330,000 options at the price of $0.10 previously granted to a third party. The proceeds will be used for general corporate purposes.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼